Rapid Therapeutic Science Laboratories, Inc. announced that it has entered into a securities purchase agreement with Sixth Street Lending, LLC for best efforts private placement of unsecured convertible promissory note original issue discount of $19,988 on January 18, 2022. The note is due on January 18, 2023. The notes will bear interest payment of 22% per annum until paid in full, accrued, unpaid interest and outstanding principal under the note is required to be paid in ten payments, each in the amount of $19,459, a total payback to investor of $194,587, with the first payment due on March 10, 2022.

The company paid one-time interest charge of 12% of the principal amount of the note $20,849 was applied on the date the note was issued. The note is convertible at a conversion price of $0.000075 per share, initially equal to a total of 4,192,772 shares of common stock. The company has reimbursed $3,750 Sixth Street Lending, LLC attorney's fees.

The securities are subject to transfer restrictions. The securities have been issued pursuant to Section 4(a)(2) and/or Rule 506 of Regulation D of the Securities Act.